Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-11 Sale |
2023-07-12 4:29 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
687 | $2.34 | $1,608 | 102,247 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 4:28 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
610 | $2.64 | $1,610 | 102,934 (Direct) |
View |
| 2023-05-11 Sale |
2023-05-15 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
562 | $2.89 | $1,624 | 103,544 (Direct) |
View |
| 2023-04-11 Sale |
2023-04-12 5:02 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
840 | $1.839 | $1,545 | 104,106 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 4:00 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
892 | $1.7532 | $1,564 | 104,946 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 4:01 pm |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
8,474 | $2.45 | $20,761 | 105,838 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 5:00 pm |
Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON Former 10% Owner |
500,000 | $2.888 | $1,444,012 | 3,824,883 (Indirect) |
View |
| 2022-06-29 Sale |
2022-07-01 4:10 pm |
Trevi Therapeutics Inc. | TRVI | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON 10% Owner |
475,966 | $2.7695 | $1,318,201 | 4,324,883 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-11 Exercise |
2023-07-12 4:29 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 102,247 (Direct) |
View |
| 2023-07-11 Exercise |
2023-07-12 4:29 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 102,247 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:14 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-27 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
6,250 | $0.511 | 95,650 (Direct) |
View |
| 2023-06-20 Exercise |
2023-06-21 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
6,250 | $0 | 95,650 (Direct) |
View |
| 2023-06-12 Exercise |
2023-06-14 4:28 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 102,934 (Direct) |
View |
| 2023-06-12 Exercise |
2023-06-14 4:28 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 102,934 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 103,544 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 103,544 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-12 5:02 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0.511 | 104,106 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-12 5:02 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,292 | $0 | 104,106 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-15 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0.511 | 104,946 (Direct) |
View |
| 2023-03-13 Exercise |
2023-03-15 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
2,291 | $0 | 104,946 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-08 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
18,750 | $0.511 | 95,650 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-08 4:00 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
18,750 | $0 | 95,650 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:34 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | Galletta Christopher See Remarks |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:30 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2023-02-16 5:26 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Simon Farrell Chief Commercial Officer |
0 | $0 | 188,150 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:23 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
187,500 | $0 | 187,500 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:18 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
187,500 | $0 | 187,500 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:13 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
375,000 | $0 | 375,000 (Direct) |
View |
| 2023-02-13 Exercise |
2023-02-15 4:01 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
27,500 | $0.511 | 105,838 (Direct) |
View |
| 2023-02-13 Exercise |
2023-02-15 4:01 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Delfini Lisa Chief Financial Officer |
27,500 | $0 | 105,838 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-14 4:43 pm |
N/A 2032-11-13 |
Trevi Therapeutics Inc. | TRVI | Clark David J Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-19 4:30 pm |
2022-09-19 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
7,500 | $0 | 37,500 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-19 4:26 pm |
2022-09-19 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
32,000 | $0 | 160,000 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:59 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:58 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:56 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:54 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Colangelo Dominick Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award(A) |
2022-07-01 4:52 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Cassella James V Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 4:51 pm |
2022-06-29 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 4:49 pm |
2022-06-29 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 4:47 pm |
2022-06-29 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
128,000 | $0 | 128,000 (Direct) |
View |
| 2022-02-11 Option Award(A) |
2022-07-01 4:44 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-02-11 Option Award(A) |
2022-07-01 4:43 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | Forbes William P Chief Development Officer |
137,500 | $0 | 137,500 (Direct) |
View |
| 2022-02-14 Option Award(A) |
2022-07-01 4:41 pm |
N/A 2032-02-13 |
Trevi Therapeutics Inc. | TRVI | GOOD JENNIFER L President & CEO |
275,000 | $0 | 275,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:04 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:01 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 4:59 pm |
N/A 2032-06-22 |
Trevi Therapeutics Inc. | TRVI | Meeker David P Director |
20,000 | $0 | 20,000 (Direct) |
View |